Cited by 719Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementGynecological conditions and treatments

Recurrence of endometriosis and its control

Guo, S.-W.·2009·Human Reproduction Update

Abstract

BACKGROUND Although surgery is currently the treatment of choice for managing endometriosis, recurrence poses a formidable challenge. To delay or to eliminate the recurrence is presently an unmet medical need in the management of endometriosis. To this end, proposals to investigate patterns of recurrence, to develop biomarkers for recurrence and to carry out biomarker-based intervention have been made. METHODS Publications pertaining to the recurrence of endometriosis and its related yet unaddressed issues were identified through MEDLINE. The reported recurrence rates, risk factors for recurrence, the effects of post-operative medication and causes of recurrence were reviewed and synthesized. In addition, several poorly explored issues such as time hazard function and mechanisms of recurrence were reviewed. Approaches to the development of biomarkers for recurrence and future intervention are discussed. RESULTS The reported recurrence rate was high, estimated as 21.5% at 2 years and 40-50% at 5 years. Few risk factors for recurrence have been consistently identified, and the evidence on the efficacy of the post-operative use of medication was scanty. The investigation on the patterns of recurrence may provide us with new insight into the possible mechanisms of recurrence and its control. The attempt to identify biomarkers for recurrence has started only very recently. CONCLUSIONS Much research is needed to better understand the patterns of recurrence and risk factors, and to develop biomarkers. One top priority is to develop biomarkers for recurrence, which may provide much needed clues to the possible mechanisms underlying recurrence and would allow the identification of patients with high recurrence risk, and permit for targeted intervention.

Integrity signals

Registry

Crossref · 10.1093/humupd/dmp007

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Laparoscopic surgery is associated with a 70%-80% probability of partial or complete pain relief.

    “Finally, patients were also informed that laparoscopic surgery was a reasonable alternative associated with a 70%-80% probability of partial or complete pain relief in case they declined medical therapy or switching from OC to a progestin, but that the risk of pain and lesion recurrence was $10% per year without long-term postoperative medical treatment (2, 3).”
  • The risk of pain and lesion recurrence after laparoscopic surgery is ≥10% per year without long-term postoperative medical treatment.

    “Finally, patients were also informed that laparoscopic surgery was a reasonable alternative associated with a 70%-80% probability of partial or complete pain relief in case they declined medical therapy or switching from OC to a progestin, but that the risk of pain and lesion recurrence was $10% per year without long-term postoperative medical treatment (2, 3).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Guo, S.-W.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
Guo, S.-W.
Venue
Human Reproduction Update
Published
2009-03-11
Volume
15
Issue
4
Pages
441-461
ISSN
  • 1355-4786 (ISSN-L)
  • 1460-2369
OpenAlex
W2132577372
Cited by
719
References
139
Citations by year
2026: 37 · 2025: 55 · 2024: 54 · 2023: 61 · 2022: 73 · 2021: 49 · 2020: 62 · 2019: 59 · 2018: 51 · 2017: 31 · 2016: 37 · 2015: 35 · 2014: 24 · 2013: 28 · 2012: 17
FWCI
2.96
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction Update (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, endometriosis recurrence, recurrence risk factors, recurrence biomarkers, postoperative medication, recurrence mechanism, recurrence rate, endometriosis surgery, targeted interventions
MeSH terms
Danazol, Endometriosis, Estrogen Antagonists, Female, Humans, Gonadotropin-Releasing Hormone, Risk Factors, Time Factors, Biomarkers, Randomized Controlled Trials as Topic, Cyclooxygenase 2, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review